English  |  正體中文  |  简体中文  |  2822924  
???header.visitor??? :  30016918    ???header.onlineuser??? :  1148
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"pei jer chen"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 391-415 of 883  (36 Page(s) Totally)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-03T03:34:47Z Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan Huang Y.-W.; Liao Y.-T.; Chen W.; Chen C.-L.; Hu J.-T.; Liu C.-J.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Yang S.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:46Z Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B Su T.-H.; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; PEI-JER CHEN; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:46Z Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; PEI-JER CHEN; Lin Z.-Z.; Chao T.-Y.; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:46Z Gender disparity of hepatocellular carcinoma: The roles of sex hormones Yeh S.-H.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:46Z Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; Tseng T.-C.; Chen C.-H.; Su W.-C.; Liu C.-J.; Chen C.-L.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:45Z Phenotypic analyses and mutation screening of the SLC26A4 and FOXI1 genes in 101 Taiwanese families with bilateral nonsyndromic enlarged vestibular aqueduct (DFNB4) or pendred syndrome Wu C.-C.; Lu Y.-C.; PEI-JER CHEN; Yeh P.-L.; Su Y.-N.; Hwu W.-L.; Hsu C.-J.
臺大學術典藏 2021-07-03T03:34:45Z Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma Omata M.; Lesmana L.A.; Tateishi R.; PEI-JER CHEN; Lin S.-M.; Yoshida H.; Kudo M.; Lee J.M.; Choi B.I.; Poon R.T.P.; Shiina S.; Cheng A.L.; Jia J.-D.; Obi S.; Han K.H.; Jafri W.; Chow P.; Lim S.G.; Chawla Y.K.; Budihusodo U.; Gani R.A.; Lesmana C.R.; Putranto T.A.; Liaw Y.F.; Sarin S.K.
臺大學術典藏 2021-07-03T03:34:45Z Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: Experts'opinion PEI-JER CHEN; Furuse J.; Han K.-H.; Hsu C.; Lim H.-Y.; Moon H.; Qin S.; Ye S.-L.; Yeoh E.-M.; Yeo W.
臺大學術典藏 2021-07-03T03:34:45Z Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases Wang H.-Y.; Chien M.-H.; Huang H.-P.; Chang H.-C.; Wu C.-C.; PEI-JER CHEN; Chang M.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:45Z Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation Chen K.-F.; Yu H.-C.; Liu T.-H.; Lee S.-S.; PEI-JER CHEN; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:44Z A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese Tsai F.-J.; Yang C.-F.; Chen C.-C.; Chuang L.-M.; Lu C.-H.; Chang C.-T.; Wang T.-Y.; Chen R.-H.; Shiu C.-F.; Liu Y.-M.; Chang C.-C.; PEI-JER CHEN; Chen C.-H.; Fann C.S.J.; Chen Y.-T.; Wu J.-Y.
臺大學術典藏 2021-07-03T03:34:44Z The evolution of real-time PCR machines to real-time PCR chips Lee D.; PEI-JER CHEN; Lee G.-B.
臺大學術典藏 2021-07-03T03:34:44Z Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I" Yu H.; Yuan Q.; Ge S.-X.; Wang H.-Y.; Zhang Y.-L.; Chen Q.-R.; Zhang J.; PEI-JER CHEN; Xia N.-S.
臺大學術典藏 2021-07-03T03:34:43Z Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection Yang H.-I.; Sherman M.; Su J.; PEI-JER CHEN; Liaw Y.-F.; Iloeje U.H.; Chen C.-J.
臺大學術典藏 2021-07-03T03:34:43Z Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population Tassaneeyakul W.; Tiamkao S.; Jantararoungtong T.; PEI-JER CHEN; Lin S.-Y.; Chen W.-H.; Konyoung P.; Khunarkornsiri U.; Auvichayapat N.; Pavakul K.; Kulkantrakorn K.; Choonhakarn C.; Phonhiamhan S.; Piyatrakul N.; Aungaree T.; Pongpakdee S.; Yodnopaglaw P.
臺大學術典藏 2021-07-03T03:34:43Z No increase in prevalence of hepatitis B Surface antigen mutant in a population of children and adolescents who were fully covered by universal infant immunization Hsu H.-Y.; Chang M.-H.; Ni Y.-H.; Chiang C.-L.; Chen H.-L.; Wu J.-F.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:42Z Combining antiangiogenic therapy with immunotherapy exerts better therapeutical effects on large tumors in a woodchuck hepatoma model Huang K.-W.; Wu H.-L.; Lin H.-L.; Liang P.-C.; PEI-JER CHEN; Chen S.-H.; Lee H.-I.; Su P.-Y.; Wu W.-H.; Lee P.-H.; Hwang L.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:42Z Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model Lin Y.-J.; Huang L.-R.; Yang H.-C.; Tzeng H.-T.; Hsu P.-N.; Wu H.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:42Z HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; Kao J.-H.; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; PEI-JER CHEN; Liu C.-J.; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:41Z Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: Long-term predictors from a community-based cohort study Lee M.-H.; Yang H.-I.; Lu S.-N.; Jen C.-L.; Yeh S.-H.; Liu C.-J.; PEI-JER CHEN; You S.-L.; Wang L.-Y.; Chen W.J.; Chen C.-J.
臺大學術典藏 2021-07-03T03:34:41Z A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients Yang T.-S.; Lu S.-N.; Chao Y.; Sheen I.-S.; Lin C.-C.; Wang T.-E.; Chen S.-C.; Wang J.-H.; Liao L.-Y.; Thomson J.A.; Wang-Peng J.; PEI-JER CHEN; Chen L.-T.
臺大學術典藏 2021-07-03T03:34:41Z Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:40Z Eastern asian expert panel opinion: Designing clinical trials of molecular targeted therapy for hepatocellular carcinoma Yeo W.; PEI-JER CHEN; Furuse J.; Han K.-H.; Hsu C.; Lim H.-Y.; Moon H.; Qin S.; Yeoh E.-M.; Ye S.-L.
臺大學術典藏 2021-07-03T03:34:40Z Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf Chen K.-F.; Tai W.-T.; Huang J.-W.; Hsu C.-Y.; Chen W.-L.; Cheng A.-L.; PEI-JER CHEN; Shiau C.-W.
臺大學術典藏 2021-07-03T03:34:40Z CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; Liu T.-H.; Hou D.-R.; PEI-JER CHEN; Cheng A.-L.

Showing items 391-415 of 883  (36 Page(s) Totally)
<< < 11 12 13 14 15 16 17 18 19 20 > >>
View [10|25|50] records per page